Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1968 Aug;44(514):603–607. doi: 10.1136/pgmj.44.514.603

The medical treatment of gastric and duodenal ulcer.

M J Langman
PMCID: PMC2466511  PMID: 5679279

Full text

PDF
603

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AIRD I., BENTALL H. H., MEHIGAN J. A., ROBERTS J. A. F. The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration. Br Med J. 1954 Aug 7;2(4883):315–321. doi: 10.1136/bmj.2.4883.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cook D. L., Bianchi R. G. SC-15396: a new antiulcer compound possessing anti-gastrin activity. Life Sci. 1967 Jul 1;6(13):1381–1387. doi: 10.1016/0024-3205(67)90185-3. [DOI] [PubMed] [Google Scholar]
  3. Craig O., Hunt T., Kimerling J. J., Parke D. V. Carbenoxolone in the treatment of duodenal ulcer. Practitioner. 1967 Jul;199(189):109–111. [PubMed] [Google Scholar]
  4. DOLL R., FRIEDLANDER P., PYGOTT F. Dietetic treatment of peptic ulcer. Lancet. 1956 Jan 7;270(6906):5–9. doi: 10.1016/s0140-6736(56)91851-7. [DOI] [PubMed] [Google Scholar]
  5. DOLL R., HILL I. D., HUTTON C. F. TREATMENT OF GASTRIC ULCER WITH CARBENOXOLONE SODIUM AND OESTROGENS. Gut. 1965 Feb;6:19–24. doi: 10.1136/gut.6.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DOLL R., JONES F. A., PYGOTT F. Effect of smoking on the production and maintenance of gastric and duodenal ulcers. Lancet. 1958 Mar 29;1(7022):657–662. doi: 10.1016/s0140-6736(58)91083-3. [DOI] [PubMed] [Google Scholar]
  7. DOLL R., PYGOTT F. Factors influencing the rate of healing of gastric ulcers; admission to hospital, phenobarbitone, and ascorbic acid. Lancet. 1952 Jan 26;1(6700):171–175. doi: 10.1016/s0140-6736(52)91405-0. [DOI] [PubMed] [Google Scholar]
  8. Doll R., Langman M. J., Shawdon H. H. Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone. Gut. 1968 Feb;9(1):42–45. doi: 10.1136/gut.9.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. EVANS P. R. Value of strict dieting, drugs, and robaden in peptic ulceration. Br Med J. 1954 Mar 13;1(4862):612–616. doi: 10.1136/bmj.1.4862.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Elmslie R. G., Mulholland A. T., Shields R. Blocking by spironolactone (SC 9420) of the action of aldosterone upon the intestinal transport of potassium, sodium, and water. Gut. 1966 Dec;7(6):697–699. doi: 10.1136/gut.7.6.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fordtran J. S., Collyns J. A. Antacid pharmacology in duodenal ulcer. Effect of antacids on postcibal gastric acidity and peptic activity. N Engl J Med. 1966 Apr 28;274(17):921–927. doi: 10.1056/NEJM196604282741701. [DOI] [PubMed] [Google Scholar]
  12. HAMMOND E. C., HORN D. Smoking and death rates; report on forty-four months of follow-up of 187,783 men. I. Total mortality. J Am Med Assoc. 1958 Mar 8;166(10):1159–1172. doi: 10.1001/jama.1958.02990100047009. [DOI] [PubMed] [Google Scholar]
  13. Horwich L., Galloway R. Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation. Br Med J. 1965 Nov 27;2(5473):1274–1277. doi: 10.1136/bmj.2.5473.1274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hunt J. N., Wales R. C. Progress in patients with peptic ulceration treated for more that five years with poldine, including a double-blind study. Br Med J. 1966 Jul 2;2(5504):13–16. doi: 10.1136/bmj.2.5504.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LENNARD-JONES J. E., BABOURIS N. EFFECT OF DIFFERENT FOODS ON THE ACIDITY OF THE GASTRIC CONTENTS IN PATIENTS WITH DUODENAL ULCER. I. A COMPARISON BETWEEN TWO 'THERAPEUTIC' DIETS AND FREELY-CHOSEN MEALS. Gut. 1965 Apr;6:113–117. doi: 10.1136/gut.6.2.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. LENNARD-JONES J. E. Experimental and clinical observations of poldine in treatment of duodenal ulcer. Br Med J. 1961 Apr 15;1(5232):1071–1076. doi: 10.1136/bmj.1.5232.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Langman M. J., Doll R. ABO blood group and secretor status in relation to clinical characteristics of peptic ulcers. Gut. 1965 Jun;6(3):270–273. doi: 10.1136/gut.6.3.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MELROSE A. G., PINKERTON I. W. Clinical evaluation of poldine methosulphate. Br Med J. 1961 Apr 15;1(5232):1076–1078. doi: 10.1136/bmj.1.5232.1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. PIPER D. W., FENTON B. H. ANTACID THERAPY OF PEPTIC ULCER. II. AN EVALUATION OF ANTACIDS IN VITRO. Gut. 1964 Dec;5:585–589. doi: 10.1136/gut.5.6.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PRICE A. V., SANDERSON P. H. Alkali requirement for continuous neutralisation of gastric contents in gastric and duodenal ulcer. Clin Sci. 1956 May;15(2):285–295. [PubMed] [Google Scholar]
  21. SUN D. C. LONG-TERM ANTICHOLINERGIC THERAPY FOR PREVENTION OF RECURRENCES IN DUODENAL ULCER. Am J Dig Dis. 1964 Oct;9:706–716. doi: 10.1007/BF02237730. [DOI] [PubMed] [Google Scholar]
  22. SZULMAN A. E. The histological distribution of blood group substances A and B in man. J Exp Med. 1960 Jun 1;111:785–800. doi: 10.1084/jem.111.6.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Szulman A. E. THE HISTOLOGICAL DISTRIBUTION OF THE BLOOD GROUP SUBSTANCES IN MAN AS DISCLOSED BY IMMUNOFLUORESCENCE : II. THE H ANTIGEN AND ITS RELATION TO A AND B ANTIGENS. J Exp Med. 1962 May 1;115(5):977–996. doi: 10.1084/jem.115.5.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. TRUELOVE S. C. Stilboestrol, phenobarbitone, and diet in chronic duodenal ulcer. A factorial therapeutic trial. Br Med J. 1960 Aug 20;2(5198):559–566. doi: 10.1136/bmj.2.5198.559. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES